This Westminster Health Forum event provides a timely opportunity to discuss the next steps for NICE - looking at measuring output, developing evidence-based guidelines and accelerating the uptake of innovation.
Delegates will assess the next steps for scaling up and overcoming barriers to increasing the number and pace of appraisals for new medicines - including utilising funding, demonstrating value and expanding the scope of innovation.
Speakers include Professor Gillian Leng, Deputy Chief Executive and Director of Health and Social Care, NICE, and Dr Alan MacDonald, Chairman, Scottish Medicines Consortium.
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.